MedPath

保定天浩制药有限公司

Ownership
-
Established
1999-11-26
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

26

NMPA:26

Drug Approvals

Oseltamivir Phosphate for Suspension

Product Name
磷酸奥司他韦干混悬剂
Approval Number
国药准字H20253060
Approval Date
Jan 2, 2025
NMPA

Donepezil Hydrochloride Tablets

Product Name
盐酸多奈哌齐片
Approval Number
国药准字H20249669
Approval Date
Dec 1, 2024
NMPA

Perindopril tert-Butylamine Tablets

Product Name
培哚普利叔丁胺片
Approval Number
国药准字H20234341
Approval Date
Oct 24, 2023
NMPA

Perindopril tert-Butylamine Tablets

Product Name
培哚普利叔丁胺片
Approval Number
国药准字H20234342
Approval Date
Oct 24, 2023
NMPA

Compound Ketoconazole Cream

Product Name
复方酮康唑软膏
Approval Number
国药准字H20083724
Approval Date
May 4, 2023
NMPA

Tretinoin Cream

Product Name
维A酸乳膏
Approval Number
国药准字H20083429
Approval Date
May 4, 2023
NMPA

Memantine Hydrochloride Tablets

Product Name
盐酸美金刚片
Approval Number
国药准字H20223855
Approval Date
Nov 15, 2022
NMPA

伤湿止痛搽剂

Approval Number
国药准字Z20133015
Approval Date
Sep 28, 2022
NMPA

金前感冒胶囊

Approval Number
国药准字Z20123084
Approval Date
Jun 17, 2022
NMPA

Apixaban Tablets

Product Name
阿哌沙班片
Approval Number
国药准字H20213757
Approval Date
Sep 30, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.